Baxter International Inc. (BAX)
Summary
BAX Chart
People also search for
Baxter International: The Gains Can Continue, But Should Slow
Baxter International has shown early signs of a turnaround, with improving execution and raised revenue guidance supporting cautious optimism. BAX's valuation has expanded from distressed levels, now trading at ~13x earnings and ~9.5x EV/EBITDA, yet remains attractive if growth continues. Management's focus on operational improvements, cost savings, and a conservative outlook suggests potential for further upside if EPS growth materializes.
BAX Stock Gains on Q2 Earnings & Sales Beat, Margins Contract
Baxter beats second-quarter earnings and revenue estimates, posts broad-based segment growth and raises its 2026 outlook despite margin pressure.
Baxter International Inc. (BAX) Q2 2026 Earnings Call Transcript
Baxter International Inc. (BAX) Q2 2026 Earnings Call Transcript
Baxter International Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 20,564 | $612,045.6 | $537,954.24 | -$74,091.36 | -12.11% |
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 200 | $15,508 | $5,232 | -$10,276 | -66.26% |
 Cyrus Pearo INVESTMENT MANAGEMENT ASSOCIATES Inc. /ADV | 778,931 | $13.09M | $20.38M | $7.29M | 55.71% |
 Curtis Ellergodt Rothschild Investment LLC | 9,492 | $364,830.12 | $258,229.86 | -$106,600.26 | -29.22% |
 Dodge & Cox Dodge & Cox Funds | 58.39M | $2.06B | $1.57B | -$489.36M | -23.72% |
Baxter International Inc. (BAX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Baxter International Inc. ever had a stock split?
Baxter International Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Andrew Hider CEO | NYSE Exchange | 071813109 CUSIP |
| US Country | 37,500 Employees | 28 Aug 2026 Last Dividend | 1 Jul 2015 Last Split | 27 Oct 1981 IPO Date |
Overview
Baxter International Inc. is a global healthcare company with a history dating back to 1931. With its headquarters in Deerfield, Illinois, Baxter specializes in the development and distribution of a wide range of healthcare products aimed at enhancing the health and well-being of people around the world. The company's operations are segmented into four key areas: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. These segments allow Baxter to serve a diverse range of healthcare needs, from critical care to chronic disease management. Baxter's commitment to innovation and quality is evident in its extensive product portfolio and its global presence, selling products in approximately 100 countries through a combination of direct sales force and distributors, including drug wholesalers and specialty pharmacy providers. The company's collaborative efforts, such as agreements with Celerity Pharmaceutical, LLC, and Miromatrix Medical Inc., underscore its dedication to advancing healthcare solutions.
Products and Services
- Sterile Intravenous (IV) Solutions
These are critical for patient hydration, medication delivery, and various forms of therapy in clinical settings.
- Infusion Systems and Devices
Baxter offers advanced infusion systems and devices that facilitate the safe and precise delivery of IV medications and therapies.
- Parenteral Nutrition Therapies
Designed for patients who cannot eat or absorb nutrients through their digestive system, these therapies provide vital nutrition intravenously.
- Generic Injectable Pharmaceuticals
The company supplies a range of generic injectables, including essential drugs for acute care settings.
- Surgical Hemostat and Sealant Products
These products are utilized to control bleeding and promote healing in surgical procedures.
- Advanced Surgical Equipment
Baxter provides state-of-the-art surgical equipment, including surgical video technologies and precision positioning devices, to enhance surgical efficiency and outcomes.
- Smart Bed Systems
These systems are designed to improve patient comfort and monitoring capabilities in healthcare settings.
- Patient Monitoring and Diagnostic Technologies
Baxter offers technologies for continuous monitoring and diagnosis of patients, aiding in timely and accurate healthcare delivery.
- Respiratory Health Devices
Devices designed to assist with breathing disorders and respiratory health management.
- Dialysis Therapies and Services
Providing a comprehensive suite of dialysis therapies and services, including peritoneal dialysis (PD) and hemodialysis (HD), Baxter supports patients with chronic kidney failure.
- Adhesion Prevention Products
These products are designed to prevent post-surgical adhesions, enhancing patient recovery and comfort.
- Drug Compounding
Baxter offers specialized compounding services, allowing for customized medication formulations to meet unique patient needs.
- Inhaled Anesthesia
Offering a range of inhaled anesthesia products, Baxter supports anesthesiologists in providing safe and effective sedation for surgical procedures.
